Pharmaxis to acquire Topigen in equity deal
This article was originally published in Scrip
Executive Summary
Pharmaxis is to acquire the private Canadian firm Topigen Pharmaceuticals in an all-stock transaction which will add to its development pipeline in the respiratory area.